The effect of intravenous dexamethasone on sugammadex reversal time in children undergoing adenotonsillectomy

Anesthesia and Analgesia

Volumn 122, Issue 4, 2016, Pages 1147-1152

  Gulec, Ersel ^a   Biricik, Ebru ^a   Turktan, Mediha ^a   Hatipoglu, Zehra ^a   Unlugenc, Hakki ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; SUGAMMADEX; TRAMADOL; GAMMA CYCLODEXTRIN DERIVATIVE;

ADENOTONSILLECTOMY; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; CHILD; DRUG EFFECT; ELECTRIC PERIPHERAL NERVE STIMULATOR; EXTUBATION; FEMALE; HEMODYNAMIC MONITORING; HUMAN; LARYNX SPASM; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROMUSCULAR MONITORING; PRIORITY JOURNAL; ADENOIDECTOMY; ADVERSE EFFECTS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TONSILLECTOMY; TREATMENT OUTCOME;

ADENOIDECTOMY; ADMINISTRATION, INTRAVENOUS; ANESTHESIA RECOVERY PERIOD; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TONSILLECTOMY; TREATMENT OUTCOME;

EID: 84954417083     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001142     Document Type: Article

References (34)

1. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008 107 130 7
2. Shorten GD, Postoperative residual curarisation: incidence, aetiology and associated morbidity. Anaesth Intensive Care 1993 21 782 9
3. Eriksson LI, The effects of residual neuromuscular blockade and volatile anesthetics on the control of ventilation. Anesth Analg 1999 89 243 51
4. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ, Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997 41 1095 103
5. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, Ehrenfeld JM, Martinez EA, Kurth T, Eikermann M, Intermediate acting non-Depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012 345 e6329
6. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T, The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol 2011 28 842 8
7. Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, Maktabi M, Lee J, Kwo J, Pino R, Sabouri AS, McGovern F, Staehr-Rye AK, Eikermann M, Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth 2015 115 743 51
8. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J, Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013 117 345 51
9. Ledowski T, Hillyard S, O'Dea B, Archer R, Vilas-Boas F, Kyle B, Introduction of sugammadex as standard reversal agent: impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Indian J Anaesth 2013 57 46 51
10. Gaszynski T, Szewczyk T, Gaszynski W, Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012 108 236 9
11. Pavoni V, Gianesello L, De Scisciolo G, Provvedi E, Horton D, Barbagli R, Conti P, Conti R, Giunta F, Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study. Minerva Anestesiol 2012 78 542 9
12. Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK, Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009 110 284 94
13. Abrishami A, Ho J, Wong J, Yin L, Chung F, Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev 2009 CD007362
14. Bom A, Hope F, Rutherford S, Thomson K, Preclinical pharmacology of sugammadex. J Crit Care 2009 24 29 35
15. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I, Effective reversal of moderate rocuronium-or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007 106 283 8
16. Steward DL, Grisel J, Meinzen-Derr J, Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev 2011 CD003997
17. Elhakim M, Ali NM, Rashed I, Riad MK, Refat M, Dexamethasone reduces postoperative vomiting and pain after pediatric tonsillectomy. Can J Anaesth 2003 50 392 7
18. Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery (DECS) Study Group Intraoperative high-Dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012 308 1761 7
19. Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ, Darrow DH, Giordano T, Litman RS, Li KK, Mannix ME, Schwartz RH, Setzen G, Wald ER, Wall E, Sandberg G, Patel MM, American Academy of Otolaryngology-Head and Neck Surgery Foundation Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011 144 S1 30
20. Rezonja K, Sostaric M, Vidmar G, Mars T, Dexamethasone produces dose-Dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle cells. Anesth Analg 2014 118 755 63
21. Murphy GS, Brull SJ, Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010 111 120 8
22. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J, 8th International Neuromuscular Meeting Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007 51 789 808
23. Zwiers A, van den Heuvel M, Smeets J, Rutherford S, Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach. Clin Drug Investig 2011 31 101 11
24. Rex C, Bergner UA, Pühringer FK, Sugammadex: a selective relaxant-binding agent providing rapid reversal. Curr Opin Anaesthesiol 2010 23 461 5
25. Rezonja K, Lorenzon P, Mars T, Opposing effects of dexamethasone, agrin and sugammadex on functional innervation and constitutive secretion of IL-6 in in vitro innervated primary human muscle cells. Neurosci Lett 2013 549 186 90
26. Aouad MT, Nasr VG, Yazbeck-Karam VG, Bitar MA, Bou Khalil M, Beyrouthy O, Harfouche D, Terrin N, Siddik-Sayyid S, A comparison between dexamethasone and methylprednisolone for vomiting prophylaxis after tonsillectomy in inpatient children: a randomized trial. Anesth Analg 2012 115 913 20
27. Celiker V, Celebi N, Canbay O, Başgül E, Aypar U, Minimum effective dose of dexamethasone after tonsillectomy. Paediatr Anaesth 2004 14 666 9
28. Kim MS, Coté CJ, Cristoloveanu C, Roth AG, Vornov P, Jennings MA, Maddalozzo JP, Sullivan C, There is no dose-Escalation response to dexamethasone (0.0625-1.0 mg/kg) in pediatric tonsillectomy or adenotonsillectomy patients for preventing vomiting, reducing pain, shortening time to first liquid intake, or the incidence of voice change. Anesth Analg 2007 104 1052 8
29. Aouad MT, Siddik SS, Rizk LB, Zaytoun GM, Baraka AS, The effect of dexamethasone on postoperative vomiting after tonsillectomy. Anesth Analg 2001 92 636 40
30. Kaan MN, Odabasi O, Gezer E, Daldal A, The effect of preoperative dexamethasone on early oral intake, vomiting and pain after tonsillectomy. Int J Pediatr Otorhinolaryngol 2006 70 73 9
31. Samarkandi AH, Shaikh MA, Ahmad RA, Alammar AY, Use of dexamethasone to reduce postoperative vomiting and pain after pediatric tonsillectomy procedures. Saudi Med J 2004 25 1636 9
32. Khani A, Jaafarpour M, Khajavikhan J, Dyrekvandmogadam A, The effect of dexamethasone on morbidity related to vomiting, pain and oral intake in children after tonsillectomy. J Clin Diagn Res 2009 3 1641 6
33. Soltész S, Fraisl P, Noé KG, Hinkelbein J, Mellinghoff H, Mencke T, Dexamethasone decreases the duration of rocuronium-induced neuromuscular block: a randomised controlled study. Eur J Anaesthesiol 2014 31 417 22
34. Czock D, Keller F, Rasche FM, Häussler U, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005 44 61 98